Publications by authors named "M Monteverde"

Article Synopsis
  • * The study uses broadband optically detected magnetic resonance (ODMR) to detect a weakly exchange-coupled triplet pair, which is influenced by light intensity and molecular orientation.
  • * The research reveals a complex interaction of multiexciton states and transitions that can inform future designs of materials for exciton fission applications.
View Article and Find Full Text PDF

Risk assessments are common in multiple domains, from finance to medicine. They require evaluating an event's potential severity and likelihood. We investigate the possible dependence of likelihood and severity within the domain of impact-based weather forecasting (IBF), following predictions derived from considering asymmetric loss functions.

View Article and Find Full Text PDF
Article Synopsis
  • * Surprisingly, exposing CrGeTe to air leads to the formation of a stable ferromagnetic phase (CrTe with T ≈ 160 K) alongside its original phase (T ≈ 69 K), revealing a complex coexistence of two magnetic states.
  • * The study uses Ginzburg-Landau theory to explain this coexistence and suggests these findings might help develop new air-stable materials with multiple magnetic phases, challenging the common notion of instability in
View Article and Find Full Text PDF

Background: In Argentina, Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli (STEC HUS), is the main cause of acute kidney injury and the second cause of end-stage renal disease (ESRD) in children. In recent decades, strategies have been implemented to reduce progression to ESRD, but it is not known whether the cumulative incidence of HUS requiring kidney transplantation (KTx) has decreased. We aimed to determine whether the cumulative incidence of STEC HUS in children undergoing KTx decreased and compared outcomes of HUS-related KTx vs.

View Article and Find Full Text PDF

Although rituximab is widely used off-label for complex pediatric diseases, safety reports are limited. We aimed to report evidence of its use in clinical practice, to describe the incidence of adverse drug reactions (ADR) to rituximab biosimilar Novex and innovator, and to identify risk factors for the development of ADR in a real-life follow-up cohort of pediatric patients with complex diseases. We conducted a prospective, longitudinal, observational, single-centre study in patients that received rituximab for any complex disease, and as part of an intensive pharmacovigilance program.

View Article and Find Full Text PDF